Kenichi Suzuki
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 10
- Cancer Treatment and Pharmacology 5
- Immunology top 10%
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 8
- Renal cell carcinoma treatment 4
- Lung Cancer Treatments and Mutations 4
-
- Nausea and vomiting management 7
- Bladder and Urothelial Cancer Treatments 5
- Anesthesia and Pain Management 4
Kenichi Suzuki
60 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Oncology 478
- Immunology 300
- Pulmonary and Respiratory Medicine 349
- Surgery 269
- Cancer Research 86
Countries citing papers authored by Kenichi Suzuki
This map shows the geographic impact of Kenichi Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenichi Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenichi Suzuki more than expected).
Fields of papers citing papers by Kenichi Suzuki
This network shows the impact of papers produced by Kenichi Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenichi Suzuki. The network helps show where Kenichi Suzuki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kenichi Suzuki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 3 | |
| 4 | 2021 | 1 | |
| 5 | 2021 | 7 | |
| 6 | 2020 | 15 | |
| 7 | 2020 | 3 | |
| 8 | Differences in tolerability of pirfenidone between elderly and younger patients with idiopathic pulmonary fibrosis | 2019 | 1 |
| 9 | 2019 | 14 | |
| 10 | 2018 | 3 | |
| 11 | 2017 | 8 | |
| 12 | 2016 | 16 | |
| 13 | 2014 | 9 | |
| 14 | 2011 | 4 | |
| 15 | 2006 | 2 | |
| 16 | 2005 | 2 | |
| 17 | [Prognosis of subacutely progressive interstitial pneumonia depends on the presence of focal usual interstitial pneumonia]. | 2001 | 1 |
| 18 | 1999 | 8 | |
| 19 | 1994 | 5 | |
| 20 | 1992 | 16 |
About Kenichi Suzuki
Kenichi Suzuki is a scholar working on Pulmonary and Respiratory Medicine, Urology and Oncology, having authored 67 papers that have together received 1.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (10 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (8 papers), Nausea and vomiting management (7 papers), Bladder and Urothelial Cancer Treatments (5 papers), Cancer Treatment and Pharmacology (5 papers), Renal cell carcinoma treatment (4 papers), Anesthesia and Pain Management (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Oncology (478 citations), Immunology (300 citations) and Pulmonary and Respiratory Medicine (349 citations). Kenichi Suzuki has collaborated with scholars based in Japan, Norway and Greece. Frequent co-authors include Seiichi Orikasa, Haruo Ohtani, Hiroshi Nagura, Osamu Nakano, Masataka Aizawa, Yoshitaka Naito, Makoto Sato, Yasuyoshi Suzuki, Senji Hoshi and Koichiro Tatsumi. Their work appears in journals such as International Journal of Urology, Oncology, Scientific Reports, Urologic Oncology Seminars and Original Investigations and Drug Design Development and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.